Billel Gasmi, MD

Assistant Research Physician
National Cancer Institute
Bethesda, Maryland, United States

Presentation(s):

• P78. Casein kinase II inhibition with proteosome inhibition demonstrates therapeutic potential in gastroenteropancreatic neuroendocrine tumor liver metastases via abrogation of NFκB signaling

  Thursday, March 5, 2026
  4:37 PM - 4:44 PM MST

• BP23. Assessment of Tumor Infiltrating Lymphocyte therapy for metastatic epithelial cancers using Patient Derived Tumor Organoids

  Friday, March 6, 2026
  2:12 PM - 2:19 PM MST